tiprankstipranks
MATERNUS-Kliniken AG (DE:MAK)
XETRA:MAK
Holding DE:MAK?
Track your performance easily

MATERNUS-Kliniken AG (MAK) Technical Analysis

0 Followers

Summary of all the Indicators

Overall Consensus
Sell
5Bullish
6Neutral
11Bearish
Technical Analysis Consensus
Neutral
2Bullish
6Neutral
2Bearish
Moving Average Consensus
Strong Sell
3Bullish
0Neutral
9Bearish
MATERNUS-Kliniken AG’s (MAK) Moving Averages Convergence Divergence (MACD) indicator is -0.05, suggesting MATERNUS-Kliniken AG is a Buy.
MATERNUS-Kliniken AG’s (MAK) 20-Day exponential moving average is 1.65, while MATERNUS-Kliniken AG’s (MAK) share price is €1.6, making it a Sell.
MATERNUS-Kliniken AG’s (MAK) 50-Day exponential moving average is 1.70, while MATERNUS-Kliniken AG’s (MAK) share price is €1.6, making it a Sell.

MATERNUS-Kliniken AG (MAK) Pivot Points

Nov 23, 2024, 11:10 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
1.60
1.60
1.60
1.60
1.60
1.60
1.60
Fibonacci
1.60
1.60
1.60
1.60
1.60
1.60
1.60
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

MATERNUS-Kliniken AG (MAK) Moving Averages

Nov 23, 2024, 11:10 PM
Period
Simple
Exponential
MA5
1.59Buy
1.59Buy
MA10
1.60Buy
1.61Sell
MA20
1.67Sell
1.65Sell
MA50
1.73Sell
1.70Sell
MA100
1.75Sell
1.76Sell
MA200
1.84Sell
1.94Sell
MATERNUS-Kliniken AG’s (MAK) 10-Day exponential moving average is 1.61, while MATERNUS-Kliniken AG’s (MAK) share price is €1.6, making it a Sell.
MATERNUS-Kliniken AG’s (MAK) 100-Day exponential moving average is 1.76, while MATERNUS-Kliniken AG’s (MAK) share price is €1.6, making it a Sell.
MATERNUS-Kliniken AG’s (MAK) stock price is €1.6 and MATERNUS-Kliniken AG’s (MAK) 50-day simple moving average is 1.73, creating a Sell signal.
MATERNUS-Kliniken AG’s (MAK) stock price is €1.6 and MATERNUS-Kliniken AG’s (MAK) 100-day simple moving average is 1.75, creating a Sell signal.
MATERNUS-Kliniken AG’s (MAK) stock price is €1.6 and MATERNUS-Kliniken AG’s (MAK) 200-day simple moving average is 1.84, creating a Sell signal.

MATERNUS-Kliniken AG (MAK) Technical Indicators

Nov 23, 2024, 11:10 PM
Name
Value
Implied Action
RSI (14)
38.51
Neutral
STOCH (9,6)
38.10
Neutral
STOCHRSI (14)
23.89
Neutral
MACD (12,26)
-0.05
Buy
ADX (14)
22.60
Neutral
Williams %R
-73.68
Buy
CCI (14)
-60.17
Neutral
ATR (14)
0.03
-
Ultimate Oscillator
48.95
Neutral
ROC
-7.51
Sell
MATERNUS-Kliniken AG’s (MAK) Relative Strength Index (RSI) is 38.51, creating a Neutral signal.
MATERNUS-Kliniken AG’s (MAK) Trend Strength Indicator (ADX) is 22.60, creating a Neutral signal.
MATERNUS-Kliniken AG’s (MAK) Commodity Channel Index (CCI) is -60.17, creating a Neutral signal.
MATERNUS-Kliniken AG’s (MAK) Price Rate of Change (ROC) is -7.51, creating a Sell signal.

FAQ

Is MAK a Buy, Hold, or Sell?
Based on MAK’s technical indicators, MAK is a Sell.
    What is MAK’s RSI (14)?
    MAK’s RSI (14) is 38.51, which suggests MAK is a Neutral.
      What is MAK’s MACD?
      MAK’s MACD is -0.05, which suggests MAK is a Buy.
        What is MAK’s 5-day moving average?
        MAK’s 5-day moving average is 1.59, which suggests MAK is a Buy.
          What is MAK’s 20-day moving average?
          MAK 20-day moving average is 1.67, which suggests MAK is a Sell.
            What is MAK’s 50-day moving average?
            MAK’s 50-day moving average is 1.73, which suggests MAK is a Sell.
              What is MAK’s 200-day moving average?
              MAK’s 200-day moving average is 1.84, which suggests MAK is a Sell.
                What is MAK’s Williams % R (14)?
                MAK’s Williams % R (14) is -73.68, which suggests MAK is a Buy.
                  What is MAK’s CCI (14)?
                  MAK’s CCI (14) is -60.17, which suggests MAK is a Neutral.
                    What is the share price of MATERNUS-Kliniken AG?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis